10310-32-4 | Tribenoside

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$29.00	$20.00
1g	95%	in stock	$46.00	$32.00
5g	95%	in stock	$199.00	$140.00
10g	95%	in stock	$283.00	$198.00
25g	95%	in stock	$573.00	$402.00

Description

• Catalog Number: AD80942
• Chemical Name: Tribenoside
• CAS Number: 10310-32-4
• Molecular Formula: C29H34O6
• Molecular Weight: 478.5767
• MDL Number: MFCD00801089
• SMILES: CCOC1O[C@@H]([C@@H]([C@H]1O)OCc1ccccc1)[C@H](OCc1ccccc1)COCc1ccccc1

Computed Properties

• Complexity: 555
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Heavy Atom Count: 35
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 13
• Undefined Atom Stereocenter Count: 1
• XLogP3: 3.9

Upstream Synthesis Route

Tribenoside, also known as 2-(3,4,5-trihydroxybenzoyl)oxybenzoic acid, is a versatile compound widely used in chemical synthesis. It serves as a crucial building block in various organic reactions, particularly in the synthesis of complex pharmaceuticals and natural products.Tribenoside's unique chemical structure makes it a valuable reagent for the formation of ester bonds, as well as in the modification of aromatic systems. This compound is frequently employed as a protecting group for hydroxyl functionalities due to its stability under a wide range of reaction conditions.In addition, Tribenoside's ability to undergo selective functionalization at different positions within its molecular framework makes it a valuable tool in designing and constructing intricate chemical architectures. Its presence in the synthesis of biologically active compounds highlights its significance in medicinal chemistry and drug discovery applications.Overall, Tribenoside plays a crucial role in the advancement of chemical synthesis strategies, enabling chemists to access novel compounds with diverse pharmacological properties.

Literature

• Teratogenic potential of tribenoside, a drug for the treatment of haemorrhoids and varicose veins--a population-based case--control study.

  Reproductive toxicology (Elmsford, N.Y.) 20110501

• The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells.

  Biological & pharmaceutical bulletin 20100101

• Allergic contact dermatitis caused by tribenoside.

  Contact dermatitis 20090601

• [Certain aspects of pathogenesis of hemorheological and trophic disturbances and their pharmacological correction in patients with chronic venous insufficiency].

  Vestnik khirurgii imeni I. I. Grekova 20080101

• Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells.

  Acta dermato-venereologica 20050101